AR031525A1 - USE OF A COMPOSITION THAT INCLUDES A MODAFINIL COMPOUND FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DIFFICULTY OF CARE AND THE FATIGUE OF MULTIPLE SCLEROSIS, PHARMACEUTICAL COMPOSITIONS, A THERAPEUTIC PACKAGING MODEL OF A SELECTIVE COMPACT - Google Patents

USE OF A COMPOSITION THAT INCLUDES A MODAFINIL COMPOUND FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DIFFICULTY OF CARE AND THE FATIGUE OF MULTIPLE SCLEROSIS, PHARMACEUTICAL COMPOSITIONS, A THERAPEUTIC PACKAGING MODEL OF A SELECTIVE COMPACT

Info

Publication number
AR031525A1
AR031525A1 ARP000104192A AR031525A1 AR 031525 A1 AR031525 A1 AR 031525A1 AR P000104192 A ARP000104192 A AR P000104192A AR 031525 A1 AR031525 A1 AR 031525A1
Authority
AR
Argentina
Prior art keywords
fatigue
care
difficulty
treatment
composition
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Matthew T Miller
Thomas E Scammell
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30442324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR031525(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of AR031525A1 publication Critical patent/AR031525A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El uso comprende un compuesto ;odafinil en una cantidad efectiva para mejorar o prevenir los síntomas de enfermedades. El compuesto de modafinil estimula la actividad de las neuronas tuberomamilares del cerebro de un sujeto. El Modafinil exhibe actividad en el área del cerebro asociada con las funciones de la vigilia normal.The use comprises a compound; odafinil in an amount effective to improve or prevent disease symptoms. Modafinil compound stimulates the activity of tuberomamillary neurons in the brain of a subject. Modafinil exhibits activity in the area of the brain associated with the functions of normal wakefulness.

ARP000104192 1999-08-16 2000-08-14 USE OF A COMPOSITION THAT INCLUDES A MODAFINIL COMPOUND FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DIFFICULTY OF CARE AND THE FATIGUE OF MULTIPLE SCLEROSIS, PHARMACEUTICAL COMPOSITIONS, A THERAPEUTIC PACKAGING MODEL OF A SELECTIVE COMPACT AR031525A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14961299P 1999-08-16 1999-08-16

Publications (1)

Publication Number Publication Date
AR031525A1 true AR031525A1 (en) 2003-09-24

Family

ID=30442324

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104192 AR031525A1 (en) 1999-08-16 2000-08-14 USE OF A COMPOSITION THAT INCLUDES A MODAFINIL COMPOUND FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DIFFICULTY OF CARE AND THE FATIGUE OF MULTIPLE SCLEROSIS, PHARMACEUTICAL COMPOSITIONS, A THERAPEUTIC PACKAGING MODEL OF A SELECTIVE COMPACT

Country Status (4)

Country Link
AR (1) AR031525A1 (en)
MY (1) MY126607A (en)
TW (1) TWI291872B (en)
ZA (1) ZA200200807B (en)

Also Published As

Publication number Publication date
TWI291872B (en) 2008-01-01
MY126607A (en) 2006-10-31
ZA200200807B (en) 2003-06-04

Similar Documents

Publication Publication Date Title
BR9909903A (en) Maximum effectiveness of substances used to improve health and well-being
ES2139132T3 (en) PHARMACEUTICAL COMPOSITIONS ACTIVE IN SLEEP DISORDERS THERAPY.
KR960700742A (en) ATOPIC DISEASE REMEDY
AR023715A1 (en) PHARMACEUTICAL COMPOSITION FOR A SUBJECT WHO NEEDS AN ELEVATION OF THE CONTENT OF NAD INTRACELLULAR, AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINE TO INCREASE THE PROTECTIVE CELLULAR RESPONSES TO GENOTOXIC STRESS IN THE SKIN
BR0013555A (en) compositions including modafinil for the treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
AR090677A2 (en) PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE
BRPI0506305A (en) skin treatment articles and methods
CL2004000931A1 (en) CONSUMABLE FILM ADAPTED TO ADHER AND DISSOLVE IN THE ORAL CAVITY THAT INCLUDES A MODIFIED ALMIDON AND A PHARMACEUTICALLY ACTIVE AGENT.
CY1111177T1 (en) FAINOTHEASINE UNION FOR INJURY HEALING
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
BR0215404A (en) process and device for reducing therapeutic dosage
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
AR039164A1 (en) VENLAFAXINE SALTS OF LOW WATER SOLUBILITY
SE9701161D0 (en) New use I
ES2158597T3 (en) BIOAROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING AND USING THEM.
BRPI0418157A (en) allogeneic tumor therapy
IT1263840B (en) ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
BRPI0411176A (en) pharmaceutical combination consisting of modafinil and another drug
BR0116972A (en) Methods and devices for administering substances to the intradermal skin layer for systemic absorption
BRPI0408601A (en) nootropic compounds, their preparation, pharmaceutical compositions containing them, and their use
HUP0200152A2 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
FI962550A0 (en) Deuterated active substances for transdermal use
BR0116653A (en) Medicinal product containing a polyamine as active substance
ES2136954T3 (en) USE OF AT LEAST ONE VICHY THERMAL WATER AS A SUBSTANCE ANTAGONIST P.
AR031525A1 (en) USE OF A COMPOSITION THAT INCLUDES A MODAFINIL COMPOUND FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DIFFICULTY OF CARE AND THE FATIGUE OF MULTIPLE SCLEROSIS, PHARMACEUTICAL COMPOSITIONS, A THERAPEUTIC PACKAGING MODEL OF A SELECTIVE COMPACT

Legal Events

Date Code Title Description
FB Suspension of granting procedure